# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(7.62) per share which missed the analyst consensus estimate of $(4.03)...
Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(5.52) per share which missed the analyst consensus estimate of $(0.23)...